Characterization of Three Pleiotropic Drug Resistance Transporter Genes and Their Participation in the Azole Resistance of Mucor circinelloides
- PMID: 33937100
- PMCID: PMC8079984
- DOI: 10.3389/fcimb.2021.660347
Characterization of Three Pleiotropic Drug Resistance Transporter Genes and Their Participation in the Azole Resistance of Mucor circinelloides
Abstract
Mucormycosis is a life-threatening opportunistic infection caused by certain members of the fungal order Mucorales. This infection is associated with high mortality rate, which can reach nearly 100% depending on the underlying condition of the patient. Treatment of mucormycosis is challenging because these fungi are intrinsically resistant to most of the routinely used antifungal agents, such as most of the azoles. One possible mechanism of azole resistance is the drug efflux catalyzed by members of the ATP binding cassette (ABC) transporter superfamily. The pleiotropic drug resistance (PDR) transporter subfamily of ABC transporters is the most closely associated to drug resistance. The genome of Mucor circinelloides encodes eight putative PDR-type transporters. In this study, transcription of the eight pdr genes has been analyzed after azole treatment. Only the pdr1 showed increased transcript level in response to all tested azoles. Deletion of this gene caused increased susceptibility to posaconazole, ravuconazole and isavuconazole and altered growth ability of the mutant. In the pdr1 deletion mutant, transcript level of pdr2 and pdr6 significantly increased. Deletion of pdr2 and pdr6 was also done to create single and double knock out mutants for the three genes. After deletion of pdr2 and pdr6, growth ability of the mutant strains decreased, while deletion of pdr2 resulted in increased sensitivity against posaconazole, ravuconazole and isavuconazole. Our result suggests that the regulation of the eight pdr genes is interconnected and pdr1 and pdr2 participates in the resistance of the fungus to posaconazole, ravuconazole and isavuconazole.
Keywords: ABC transporter; CRISPR-Cas9; Mucor; azole; pleiotropic drug resistance.
Copyright © 2021 Nagy, Kiss, Varghese, Bauer, Szebenyi, Kocsubé, Homa, Bodai, Zsindely, Nagy, Vágvölgyi and Papp.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Characterization of the Sterol 24-C-Methyltransferase Genes Reveals a Network of Alternative Sterol Biosynthetic Pathways in Mucor lusitanicus.Microbiol Spectr. 2023 Jun 15;11(3):e0031523. doi: 10.1128/spectrum.00315-23. Epub 2023 Apr 10. Microbiol Spectr. 2023. PMID: 37036336 Free PMC article.
-
Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.Antimicrob Agents Chemother. 2015 Oct 19;60(1):229-38. doi: 10.1128/AAC.02157-15. Print 2016 Jan. Antimicrob Agents Chemother. 2015. PMID: 26482310 Free PMC article.
-
Relative Contribution of the ABC Transporters Cdr1, Pdh1, and Snq2 to Azole Resistance in Candida glabrata.Antimicrob Agents Chemother. 2018 Sep 24;62(10):e01070-18. doi: 10.1128/AAC.01070-18. Print 2018 Oct. Antimicrob Agents Chemother. 2018. PMID: 30038038 Free PMC article.
-
The ergosterol biosynthesis pathway, transporter genes, and azole resistance in Aspergillus fumigatus.Med Mycol. 2005 May;43 Suppl 1:S313-9. doi: 10.1080/13693780400029114. Med Mycol. 2005. PMID: 16110826 Review.
-
Novel triazole antifungal drugs: focus on isavuconazole, ravuconazole and albaconazole.Curr Opin Investig Drugs. 2010 Feb;11(2):165-74. Curr Opin Investig Drugs. 2010. PMID: 20112166 Review.
Cited by
-
Miltefosine: A Repurposing Drug against Mucorales Pathogens.J Fungi (Basel). 2023 Dec 4;9(12):1166. doi: 10.3390/jof9121166. J Fungi (Basel). 2023. PMID: 38132767 Free PMC article.
-
Rise of mucormycosis during the COVID-19 pandemic and the challenges faced.Curr Med Mycol. 2023 Mar;9(1):44-55. doi: 10.18502/cmm.2023.345032.1400. Curr Med Mycol. 2023. PMID: 37867589 Free PMC article. Review.
-
Advances in understanding infections caused by the basal fungus Mucor.PLoS Pathog. 2023 Jun 1;19(6):e1011394. doi: 10.1371/journal.ppat.1011394. eCollection 2023 Jun. PLoS Pathog. 2023. PMID: 37262085 Free PMC article. No abstract available.
-
Characterization of the Sterol 24-C-Methyltransferase Genes Reveals a Network of Alternative Sterol Biosynthetic Pathways in Mucor lusitanicus.Microbiol Spectr. 2023 Jun 15;11(3):e0031523. doi: 10.1128/spectrum.00315-23. Epub 2023 Apr 10. Microbiol Spectr. 2023. PMID: 37036336 Free PMC article.
-
Promising Antifungal Molecules against Mucormycosis Agents Identified from Pandemic Response Box®: In Vitro and In Silico Analyses.J Fungi (Basel). 2023 Jan 31;9(2):187. doi: 10.3390/jof9020187. J Fungi (Basel). 2023. PMID: 36836302 Free PMC article.
References
-
- Benito E. P., Díaz-Mínguez J. M., Iturriaga E. A., Campuzano V., Eslava A. P. (1992). Cloning and sequence analysis of the Mucor circinelloides pyrG gene encoding orotidine-5’-monophosphate decarboxylase: use of pyrG for homologous transformation. Gene 116, 59–67. 10.1016/0378-1119(92)90629-4 - DOI - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
